Expression profile of tuberin and some potential tumorigenic factors in 60 patients with uterine leiomyomata

Modern Pathology

Volumn 18, Issue 2, 2005, Pages 179-188

  Wei, Jianjun ^a   Chiriboga, Luis ^a   Mizuguchi, Masashi ^b   Yee, Herman ^a   Mittal, Khush ^a,c  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JICHI MEDICAL UNIVERSITY   (Japan)

^c BELLEVUE HOSPITAL CENTER   (United States)

Author keywords

Cluster analysis; High mobility group protein gene A2; Insulin signaling pathway; Steroid hormone receptor cofactors; Steroid hormone receptors; Tissue microarray; Tuberous sclerosis complex proteins; Uterine leiomyomata

Indexed keywords

GLUCOCORTICOID RECEPTOR; HAMARTIN; HIGH MOBILITY GROUP A2 PROTEIN; INSULIN; INSULIN LIKE GROWTH FACTOR RECEPTOR BETA; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN; PROTEIN KINASE B; SOMATOMEDIN C; SOMATOMEDIN RECEPTOR; STEROID RECEPTOR; TUBERIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CARCINOGENICITY; ENZYME REGULATION; FEMALE; GENE; GENE DELETION; GENE LOSS; HUMAN; HUMAN TISSUE; HYSTERECTOMY; IMMUNOHISTOCHEMISTRY; INCIDENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT STRAIN; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; TISSUE MICROARRAY; UTERUS MYOMA;

ADULT; AGE FACTORS; AGED; CLUSTER ANALYSIS; FEMALE; HMGB1 PROTEIN; HUMANS; IMMUNOHISTOCHEMISTRY; INSULIN-LIKE GROWTH FACTOR I; LEIOMYOMA; MIDDLE AGED; RECEPTORS, STEROID; REPRESSOR PROTEINS; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS; UTERINE NEOPLASMS;

EID: 13244269807     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: 10.1038/modpathol.3800283     Document Type: Article

References (39)

1. Flake GP, Andersen J, Dixon D. Etiology and pathogenesis of uterine leiomyomas: a review. Environ Health Perspect 2003;111:1037-1054.
2. Dixon D, He H, Haseman JK. Immunohistochemical localization of growth factors and their receptors in uterine leiomyomas and matched myometrium. Environ Health Perspect 2000;108(Suppl 5):795-802.
3. Van de Ven WJ. Genetic basis of uterine leiomyoma: involvement of high mobility group protein genes. Eur J Obstet Gynecol Reprod Biol 1998;81:289-293.
4. Nibert M, Heim S. Uterine leiomyoma cytogenetics. Genes Chromosomes Cancer 1990;2:3-13.
5. Tallini G, Vanni R, Manfioletti G, et al. High-mobility group protein gene A2 and HMGI(Y) immunoreactivity correlates with cytogenetic abnormalities in lipomas, pulmonary chondroid hamartomas, endometrial polyps, and uterine leiomyomas and is compatible with rearrangement of the high-mobility group protein gene A2 and HMGI(Y) genes. Lab Invest 2000;80:359-369.
6. Klotzbucher M, Wasserfall A, Fuhrmann U. Misexpression of wild-type and truncated isoforms of the high-mobility group I proteins high-mobility group protein gene A2 and HMGI(Y) in uterine leiomyomas. Am J Pathol 1999;155:1535-1542.
7. Quade BJ, Weremowicz S, Neskey DM, et al. Fusion transcripts involving HMGA2 are not a common molecular mechanism in uterine leiomyomata with rearrangements in 12q15. Cancer Res 2003;63:1351-1358.
8. Skubitz KM, Skubitz AP. Differential gene expression in leiomyosarcoma. Cancer 2003;98:1029-1038.
9. Catherino WH, Prupas C, Tsibris JC, et al. Strategy for elucidating differentially expressed genes in leiomyomata identified by microarray technology. Fertil Steril 2003;80:282-290.
10. Tsibris JC, Segars J, Coppola D, et al. Insights from gene arrays on the development and growth regulation of uterine leiomyomata. Fertil Steril 2002;78:114-121.
11. Tomlinson IP, Alam NA, Rowan AJ, et al. Germline mutations in fumarate hydratase predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer. Nat Genet 2002;30:406-410.
12. Everitt JI, Goldsworthy TL, Wolf DC, et al. Hereditary renal cell carcinoma in the Eker rat: a unique animal model for the study of cancer susceptibility. Toxicol Lett 1995;82-83:621-625.
13. Burroughs KD, Howe SR, Okubo Y, et al. Dysregulation of IGF-I signaling in uterine leiomyoma. J Endocrinol 2002;172:83-93.
14. Hunter DS, Klotzbucher M, Kugoh H, et al. Aberrant expression of HMGA2 in uterine leiomyoma associated with loss of tuberous sclerosis gene 2 tumor suppressor gene function. Cancer Res 2002;62:3766-3772.
15. Wei J, Li P, Chiriboga L, et al. Tuberous sclerosis in a 19-week fetus: immunohistochemical and molecular study of hamartin and tuberin. Pediatr Dev Pathol 2002;5:448-464.
16. Gao X, Pan D. Tuberous sclerosis gene 1 and tuberous sclerosis gene 2 tumor suppressors antagonize insulin signaling in cell growth. Genes Dev 2001;15:1383-1392.
17. Montagne J, Radimerski T, Thomas G. Insulin signaling: lessons from the Drosophila tuberous sclerosis complex, a tumor suppressor. Sci STKE 2001;2001: PE36.
18. Parry L, Maynard JH, Patel A, et al. Molecular analysis of the tuberous sclerosis gene 1 and tuberous sclerosis gene 2 tumour suppressor genes in sporadic glial and glioneuronal tumours. Hum Genet 2000;107:350-356.
19. Smolarek TA, Wessner LL, McCormack FX, et al. Evidence that lymphangiomyomatosis is caused by tuberous sclerosis gene 2 mutations: chromosome 16p13 loss of heterozygosity in angiomyolipomas and lymph nodes from women with lymphangiomyomatosis. Am J Hum Genet 1998;62:810-815.
20. Yu J, Astrinidis A, Henske EP. Chromosome 16 loss of heterozygosity in tuberous sclerosis and sporadic lymphangiomyomatosis. Am J Respir Crit Care Med 2001;164:1537-1540.
21. Mizuguchi M, Kato M, Yamanouchi H, et al. Loss of tuberin from cerebral tissues with tuberous sclerosis and astrocytoma. Ann Neurol 1996;40:941-944.
22. Mizuguchi M, Ikeda K, Takashima S. Simultaneous loss of hamartin and tuberin from the cerebrum, kidney and heart with tuberous sclerosis. Acta Neuropathol 2000;99:503-510.
23. Mizuguchi M, Kato M, Yamanouchi H, et al. Tuberin immunohistochemistry in brain, kidneys and heart with or without tuberous sclerosis. Acta Neuropathol 1997;94:525-531.
24. Nisolle M, Casanas-Roux F, Marbaix E, et al. Transplantation of cultured explants of human endometrium into nude mice. Hum Reprod 2000;15:572-577.
25. Eisen MB, Spellman PT, Brown PO, et al. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 1998;95:14863-14868.
26. Liu CL, Prapong W, Natkunam Y, et al. Software tools for high-throughput analysis and archiving of immunohistochemistry staining data obtained with tissue microarrays. Am J Pathol 2002;161:1557-1565.
27. Potter CJ, Pedraza LG, Xu T. Akt regulates growth by directly phosphorylating Tsc2. Nat Cell Biol 2002;4:658-665.
28. Englund K, Lindblom B, Carlstrom K, et al. Gene expression and tissue concentrations of IGF-I in human myometrium and fibroids under different hormonal conditions. Mol Hum Reprod 2000;6:915-920.
29. Giudice LC, Irwin JC, Dsupin BA, et al. Insulin-like growth factor (IGF), IGF binding protein (IGFBP), and IGF receptor gene expression and IGFBP synthesis in human uterine leiomyomata. Hum Reprod 1993;8:1796-1806.
30. Kovacs KA, Lengyel F, Kornyei JL, et al. Differential expression of Akt/protein kinase B, Bcl-2 and Bax proteins in human leiomyoma and myometrium. J Steroid Biochem Mol Biol 2003;87:233-240.
31. Shiozawa T, Shih HC, Miyamoto T, et al. Cyclic changes in the expression of steroid receptor coactivators and corepressors in the normal human endometrium. J Clin Endocrinol Metab 2003;88:871-878.
32. Henry KW, Yuan X, Koszewski NJ, et al. Tuberous sclerosis gene 2 product modulates transcription mediated by steroid hormone receptor family members. J Biol Chem 1998;273:20535-20539.
33. Korgun ET, Dohr G, Desoye G, et al. Expression of insulin, insulin-like growth factor I and glucocorticoid receptor in rat uterus and embryo during decidualization, implantation and organogenesis. Reproduction 2003;125:75-84.
34. Wei J, Chiriboga L, Yee H, et al. Altered cellular distribution of tuberin and glucocorticoid receptor in sporadic fundic gland polyps. Mod Pathol 2002;15:862-869.
35. Guller S, Markiewicz L, Wozniak R, et al. Developmental regulation of glucocorticoid-mediated effects on extracellular matrix protein expression in the human placenta. Endocrinology 1994;134:2064-2071.
36. Inoki K, Li Y, Zhu T, et al. Tuberous sclerosis gene 2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Nat Cell Biol 2002;4:648-657.
37. Gao Z, Matsuo H, Wang Y, et al. Upregulation by IGF-I of proliferating cell nuclear antigen and Bcl-2 protein expression in human uterine leiomyoma cells. J Clin Endocrinol Metab 2001;86:5593-5599.
38. Hisaoka M, Sheng WQ, Tanaka A, et al. HMGIC alterations in smooth muscle tumors of soft tissues and other sites. Cancer Genet Cytogenet 2002;138:50-55.
39. Tallini G, Dal Gin P. HMGI(Y) and high-mobility group protein gene A2 dysregulation: a common occurrence in human tumors. Adv Anat Pathol 1999;6:237-246.